Ranking Magnetic Colloid Performance for Magnetic Particle Imaging and Magnetic Particle Hyperthermia

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Medical Imaging

Background:

• Magnetic particle imaging (MPI) and magnetic particle hyperthermia (MPH) are advanced cancer therapies utilizing magnetic nanoparticles (MNPs).
• Clinical implementation requires MNPs suitable for both MPI signal generation and MPH heat delivery.
• Conflicting demands on MNP magnetic properties from each modality necessitate a robust evaluation framework.

Purpose of the Study:

• To develop a performance-based measurement and ranking scheme for evaluating MNP formulations for combined MPI and MPH applications.
• To streamline the selection process for clinically viable MNP candidates.

Main Methods:

• A figure of merit (FoM) was developed by combining measured MPI point-spread function (PSF) and specific loss power (SLP).
• Twelve iron-containing MNP formulations were evaluated using the FoM.
• In vivo validation was performed using MNPs with high, medium, and low FoM values in 4T1 tumor models.

Main Results:

• The FoM accurately ranked MNP performance for both MPI and MPH.
• Higher FoM rankings correlated with improved image quality and increased tumor temperature rise.
• MPI signal intensity demonstrated a correlation with MNP concentration in tissue.
• Computational models, incorporating MPI data, accurately predicted experimental temperature outcomes.

Conclusions:

• The developed FoM provides a reliable method for assessing MNP suitability for dual-mode MPI/MPH cancer therapy.
• The findings validate the predictive power of the FoM for in vivo performance.
• Accurate MNP quantitation and high MPI spatial resolution are crucial for optimizing therapeutic outcomes.